Interacting Drugs |
Perphenazine vs Anti-Parkinson's Agents (Dopamine Agonist) |
Security Level |
|
Mechanism |
Anti-Parkinson's Agents (Dopamine Agonist): May diminish the therapeutic effect of Antipsychotics (Typical). Antipsychotics (Typical) may enhance the therapeutic effect of Anti-Parkinson's Agents (Dopamine Agonist). |
Management |
Avoid concomitant therapy if possible and monitor for decreased effects of both agents when these combinations cannot be avoided. Atypical antipsychotics such as clozapine and quetiapine may be less likely to reduce the effects of anti-Parkinson's agents. |
Perphenazine vs Anti-Parkinson’s Agents (Dopamine Agonist)
Post Review about Perphenazine vs Anti-Parkinson’s Agents (Dopamine Agonist) Click here to cancel reply.
Other Interactions of Perphenazine
Other Interactions of Anti-Parkinson's Agents (Dopamine Agonist)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.